Insmed Incorporated
Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
INSM Key Statistics
Stock Snapshot
The current Insmed Incorporated(INSM) stock price is $143.93, with a market capitalization of 31.04B. The stock trades at a price-to-earnings (P/E) ratio of -22.48.
On 2026-03-18, Insmed Incorporated(INSM) stock opened at $144.50, reached a high of —, and a low of —.
The Insmed Incorporated(INSM)'s current trading volume is 0, compared to an average daily volume of 1.87M.
In the last year, Insmed Incorporated(INSM) shares hit a 52-week high of $212.75 and a 52-week low of $60.40.
In the last year, Insmed Incorporated(INSM) shares hit a 52-week high of $212.75 and a 52-week low of $60.40.
INSM News
Wondering whether Insmed at around US$144.60 a share looks expensive or still has room to run? This breakdown will help you connect the recent share price with...
Jefferies assumed coverage of Insmed (INSM) with a Buy rating and a price target of $228, up from $219. Insmed is to the respiratory space like Vertex Pharmaceu...
Analyst ratings
95%
of 21 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.